Cargando…
Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
BACKGROUND: Cisplatin resistance is a serious problem in cancer treatment. To overcome it, alternative approaches including virotherapy are being pursued. One of the candidates for anticancer virotherapy is the Newcastle disease virus (NDV). Even though NDV's oncolytic properties in various can...
Autores principales: | Jamal, Mohd-Hafifi, Ch’ng, Wei-Choong, Yusoff, Khatijah, Shafee, Norazizah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495217/ https://www.ncbi.nlm.nih.gov/pubmed/22853623 http://dx.doi.org/10.1186/1475-2867-12-35 |
Ejemplares similares
-
Viral persistence in colorectal cancer cells infected by Newcastle disease virus
por: Chia, Suet-Lin, et al.
Publicado: (2014) -
Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent
por: Baradaran, Ali, et al.
Publicado: (2016) -
Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters
por: Ch’ng, Wei-Choong, et al.
Publicado: (2012) -
Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein
por: Mustafa, Suhaili, et al.
Publicado: (2020) -
Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53
por: Abd-Aziz, Noraini, et al.
Publicado: (2016)